A.M. Gibson

894 total citations
31 papers, 657 citations indexed

About

A.M. Gibson is a scholar working on Oncology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, A.M. Gibson has authored 31 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Cellular and Molecular Neuroscience and 11 papers in Physiology. Recurrent topics in A.M. Gibson's work include Peptidase Inhibition and Analysis (18 papers), Neuropeptides and Animal Physiology (15 papers) and Alzheimer's disease research and treatments (11 papers). A.M. Gibson is often cited by papers focused on Peptidase Inhibition and Analysis (18 papers), Neuropeptides and Animal Physiology (15 papers) and Alzheimer's disease research and treatments (11 papers). A.M. Gibson collaborates with scholars based in United Kingdom, United States and Australia. A.M. Gibson's co-authors include J.R. McDermott, Brenda Lauffart, David Mantle, J.A. Biggins, Christopher M. Morris, Clive Ballard, J.A. Edwardson, Andrew Singleton, John Hardy and Paul G. Ince and has published in prestigious journals such as Neurology, Biological Psychiatry and Biochemical and Biophysical Research Communications.

In The Last Decade

A.M. Gibson

31 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Gibson United Kingdom 16 323 278 220 201 72 31 657
David Muyllaert Belgium 8 337 1.0× 317 1.1× 149 0.7× 62 0.3× 103 1.4× 10 679
Marco Angelo United Kingdom 6 262 0.8× 265 1.0× 238 1.1× 50 0.2× 75 1.0× 6 602
Carme Espinet Spain 15 161 0.5× 506 1.8× 317 1.4× 44 0.2× 40 0.6× 28 881
R Bhasin United States 9 415 1.3× 401 1.4× 64 0.3× 58 0.3× 74 1.0× 11 609
Cheryl Marietta United States 17 75 0.2× 487 1.8× 165 0.8× 77 0.4× 23 0.3× 27 908
Xiuhai Ren United States 14 156 0.5× 261 0.9× 213 1.0× 45 0.2× 42 0.6× 24 584
Inga Volkmann Sweden 11 474 1.5× 268 1.0× 155 0.7× 66 0.3× 96 1.3× 14 706
Soledad Galli Argentina 12 169 0.5× 418 1.5× 130 0.6× 43 0.2× 19 0.3× 14 652
Koon‐Sea Hui United States 12 107 0.3× 260 0.9× 253 1.1× 177 0.9× 34 0.5× 30 463
Helen K. Warwick United Kingdom 4 249 0.8× 218 0.8× 138 0.6× 37 0.2× 38 0.5× 5 477

Countries citing papers authored by A.M. Gibson

Since Specialization
Citations

This map shows the geographic impact of A.M. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Gibson more than expected).

Fields of papers citing papers by A.M. Gibson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Gibson. The network helps show where A.M. Gibson may publish in the future.

Co-authorship network of co-authors of A.M. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Gibson. A scholar is included among the top collaborators of A.M. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Gibson. A.M. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ballard, Clive, et al.. (2021). Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's Disease. The Journal of Prevention of Alzheimer s Disease. 8(1). 78–83. 16 indexed citations
3.
Myers, Amanda, Mona Kaleem, Lauren Marlowe, et al.. (2005). [P‐085]: The H1c haplotype of the MAPT locus is associated with autopsy confirmed late onset Alzheimer's disease. Alzheimer s & Dementia. 1(1S_Part_2). 1 indexed citations
4.
Margallo‐Lana, M. L., Christopher M. Morris, A.M. Gibson, et al.. (2004). Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology. 62(11). 1996–1998. 33 indexed citations
5.
Morris, Christopher M., Kirsty O’Brien, A.M. Gibson, John Hardy, & Andrew Singleton. (2003). Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease. Neuroscience Letters. 352(2). 151–153. 25 indexed citations
6.
Singleton, Andrew, A.M. Gibson, Ian G. McKeith, et al.. (1999). α2-Macroglobulin polymorphisms in Alzheimerʼs disease and dementia with Lewy bodies. Neuroreport. 10(7). 1507–1510. 24 indexed citations
7.
McDermott, J.R. & A.M. Gibson. (1997). Degradation of Alzheimer's ß-Amyloid Protein by Human and Rat Brain Peptidases: Involvement of Insulin-Degrading Enzyme. Neurochemical Research. 22(1). 49–56. 157 indexed citations
8.
McDermott, J.R. & A.M. Gibson. (1996). Degradation of Alzheimerʼs β-amyloid protein by human cathepsin D. Neuroreport. 7(13). 2163–2166. 56 indexed citations
9.
Wilson, C. A., A.M. Gibson, & J.R. McDermott. (1993). Purification and characterization of tripeptidylpeptidase-II from post-mortem human brain. Neurochemical Research. 18(7). 743–749. 15 indexed citations
10.
McDermott, J.R., J.A. Biggins, & A.M. Gibson. (1992). Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer β-amyloid protein from its precursor. Biochemical and Biophysical Research Communications. 185(2). 746–752. 28 indexed citations
11.
McDermott, J.R., A.M. Gibson, Arthur E. Oakley, & J.A. Biggins. (1991). Multicatalytic, High‐Mr Endopeptidase from Postmortem Human Brain. Journal of Neurochemistry. 56(5). 1509–1517. 13 indexed citations
12.
McDermott, J.R. & A.M. Gibson. (1991). The processing of Alzheimer A4/β-amyloid protein precursor: Identification of a human brain metallopeptidase which cleaves -Lys-Leu- in a model peptide. Biochemical and Biophysical Research Communications. 179(3). 1148–1154. 26 indexed citations
13.
Mantle, David, Brenda Lauffart, & A.M. Gibson. (1991). Purification and characterization of leucyl aminopeptidase and pyroglutamyl aminopeptidase from human skeletal muscle. Clinica Chimica Acta. 197(1). 35–45. 31 indexed citations
14.
Mantle, David, Brenda Lauffart, J.R. McDermott, & A.M. Gibson. (1990). Characterization of aminopeptidases in human kidney soluble fraction. Clinica Chimica Acta. 187(2). 105–113. 37 indexed citations
15.
Gibson, A.M., J.R. McDermott, Brenda Lauffart, & David Mantle. (1989). Specificity of action of human brain alanyl aminopeptidase on Leu-enkephalin and dynorphin-related peptides. Neuropeptides. 13(4). 259–262. 22 indexed citations
16.
McDermott, J.R., J.A. Biggins, A. Ian Smith, et al.. (1988). Removal of Arg1 and Phe22 from CLIP (ACTH18–39) by rodent pituitary and blood peptidases. Peptides. 9(4). 757–761. 5 indexed citations
17.
McDermott, J.R., David Mantle, Brenda Lauffart, A.M. Gibson, & J.A. Biggins. (1988). Purification and Characterization of Two Soluble C1−‐Activated Arginyl Aminopeptidases from Human Brain and Their Endopeptidase Action on Neuropeptides. Journal of Neurochemistry. 50(1). 176–182. 29 indexed citations
18.
Charlton, Bruce G., I. Nicol Ferrier, A.M. Gibson, et al.. (1987). A preliminary study of plasma αMSH concentrations in depressed patients and normal subjects. Biological Psychiatry. 22(10). 1276–1279. 2 indexed citations
19.
Coggins, Philip J., J.R. McDermott, Christopher R. Snell, & A.M. Gibson. (1987). Thyrotrophin releasing hormone degradation by rat synaptosomal peptidases: Production of the metabolite His-Pro. Neuropeptides. 10(2). 147–156. 7 indexed citations
20.
McDermott, J.R., A.M. Gibson, & John D. Turner. (1987). Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices. Biochemical and Biophysical Research Communications. 146(1). 154–158. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Muyllaert Breakdown of academic impact, for papers by Marco Angelo Breakdown of academic impact, for papers by Carme Espinet Breakdown of academic impact, for papers by R Bhasin Breakdown of academic impact, for papers by Cheryl Marietta Breakdown of academic impact, for papers by Xiuhai Ren Breakdown of academic impact, for papers by Inga Volkmann Breakdown of academic impact, for papers by Soledad Galli Breakdown of academic impact, for papers by Koon‐Sea Hui Breakdown of academic impact, for papers by Helen K. Warwick
Rankless by CCL
2026